Week seven and beyond: results phase Post-purging skin often looks better than it did before you started
3.4 What Do the Guidelines Say
On 19 March 2026, the FDA approved a higher-dose formulation of semaglutide, Wegovy HD, at 7.2 mg for once-weekly subcutaneous administration
The Preconditioning of Tumor, Tumor Microenvironment and the Immune System to Immunotherapy (PROMIT, NCT04225390) study is a multicenter single-arm phase 2 trial 53 investigating the clinical activity of ICI after administration of dacarbazine (DTIC) in patients with unresectable or metastatic melanoma with primary resistance to anti-PD-1 or PD-1 plus anti-cytotoxic-T-lymphocyte antigen 4 (CTLA-4) blockade therapy
Heres the science behind its potential gut healing, and even colon cancer prevention
Off-label veterinary use and animal studies indicate that it is in general well tolerated, although it is not FDA approved for dogs , and should only be used under veterinary supervision